136 related articles for article (PubMed ID: 29800403)
1. Association of patient navigation with care coordination in an Lynch syndrome screening program.
Miesfeldt S; Feero WG; Lucas FL; Rasmussen K
Transl Behav Med; 2018 May; 8(3):450-455. PubMed ID: 29800403
[TBL] [Abstract][Full Text] [Related]
2. Initiation of universal tumor screening for Lynch syndrome in colorectal cancer patients as a model for the implementation of genetic information into clinical oncology practice.
Cohen SA; Laurino M; Bowen DJ; Upton MP; Pritchard C; Hisama F; Jarvik G; Fichera A; Sjoding B; Bennett RL; Naylor L; Jacobson A; Burke W; Grady WM
Cancer; 2016 Feb; 122(3):393-401. PubMed ID: 26480326
[TBL] [Abstract][Full Text] [Related]
3. Universal tumor screening for lynch syndrome on colorectal cancer biopsies impacts surgical treatment decisions.
Vazzano J; Tomlinson J; Stanich PP; Pearlman R; Kalady MF; Chen W; Hampel H; Frankel WL
Fam Cancer; 2023 Jan; 22(1):71-76. PubMed ID: 35732921
[TBL] [Abstract][Full Text] [Related]
4. Challenges in the diagnosis and management of Lynch Syndrome in an Indigenous family living in a remote West Australian community.
Schofield L; Goldblatt J; Iacopetta B
Rural Remote Health; 2011; 11(4):1836. PubMed ID: 22188021
[TBL] [Abstract][Full Text] [Related]
5. Identifying patients with Lynch syndrome using a universal tumor screening program in an integrated healthcare system.
Crain PR; Zepp JM; Gille S; Jenkins L; Kauffman TL; Shuster E; Goddard KAB; Wilfond BS; Hunter JE
Hered Cancer Clin Pract; 2022 Apr; 20(1):17. PubMed ID: 35436948
[TBL] [Abstract][Full Text] [Related]
6. Impact of an immunohistochemistry-based universal screening protocol for Lynch syndrome in endometrial cancer on genetic counseling and testing.
Frolova AI; Babb SA; Zantow E; Hagemann AR; Powell MA; Thaker PH; Gao F; Mutch DG
Gynecol Oncol; 2015 Apr; 137(1):7-13. PubMed ID: 25617771
[TBL] [Abstract][Full Text] [Related]
7. Comparing universal Lynch syndrome tumor-screening programs to evaluate associations between implementation strategies and patient follow-through.
Cragun D; DeBate RD; Vadaparampil ST; Baldwin J; Hampel H; Pal T
Genet Med; 2014 Oct; 16(10):773-82. PubMed ID: 24651603
[TBL] [Abstract][Full Text] [Related]
8. Impact of routine mismatch repair screening on genetic counseling and surgical management in colorectal cancer patients.
Koch KE; Goffredo P; Hrabe JE; Gribovskaja-Rupp I; Snow AN; Bellizzi AM; Kapadia MR
Am J Surg; 2021 Aug; 222(2):408-412. PubMed ID: 33317812
[TBL] [Abstract][Full Text] [Related]
9. Success of referral to genetic counseling after positive lynch syndrome screening test.
Irons RF; Contino KM; Horte JJ; Levin B; Mattie KD; Wight M; Kwiatt ME; Behling KC; Edmonston TB; McClane SJ
Int J Colorectal Dis; 2017 Sep; 32(9):1345-1348. PubMed ID: 28664346
[TBL] [Abstract][Full Text] [Related]
10. Implementation of tumor testing for lynch syndrome in endometrial cancers at a large academic medical center.
Moline J; Mahdi H; Yang B; Biscotti C; Roma AA; Heald B; Rose PG; Michener C; Eng C
Gynecol Oncol; 2013 Jul; 130(1):121-6. PubMed ID: 23612316
[TBL] [Abstract][Full Text] [Related]
11. Association of tumor morphology with mismatch-repair protein status in older endometrial cancer patients: implications for universal versus selective screening strategies for Lynch syndrome.
Rabban JT; Calkins SM; Karnezis AN; Grenert JP; Blanco A; Crawford B; Chen LM
Am J Surg Pathol; 2014 Jun; 38(6):793-800. PubMed ID: 24503759
[TBL] [Abstract][Full Text] [Related]
12. Implementation of a Population-Based Cancer Family History Screening Program for Lynch Syndrome.
Lahiri S; Pirzadeh-Miller S; Moriarty K; Kubiliun N
Cancer Control; 2023; 30():10732748231175011. PubMed ID: 37161761
[TBL] [Abstract][Full Text] [Related]
13. Performance characteristics of a brief Family History Questionnaire to screen for Lynch syndrome in women with newly diagnosed endometrial cancer.
Eiriksson L; Aronson M; Clarke B; Mojtahedi G; Massey C; Oza AM; Gallinger S; Pollett A; Mackay H; Bernardini MQ; Ferguson SE
Gynecol Oncol; 2015 Feb; 136(2):311-6. PubMed ID: 25529831
[TBL] [Abstract][Full Text] [Related]
14. Universal tumor screening for Lynch syndrome: Assessment of the perspectives of patients with colorectal cancer regarding benefits and barriers.
Hunter JE; Zepp JM; Gilmore MJ; Davis JV; Esterberg EJ; Muessig KR; Peterson SK; Syngal S; Acheson LS; Wiesner GL; Reiss JA; Goddard KA
Cancer; 2015 Sep; 121(18):3281-9. PubMed ID: 26036338
[TBL] [Abstract][Full Text] [Related]
15. Increasing Lynch syndrome identification through establishment of a hereditary colorectal cancer registry.
Sturgeon D; McCutcheon T; Geiger TM; Muldoon RL; Herline AJ; Wise PE
Dis Colon Rectum; 2013 Mar; 56(3):308-14. PubMed ID: 23392144
[TBL] [Abstract][Full Text] [Related]
16. A Prospective Six Sigma Quality Improvement Trial to Optimize Universal Screening for Genetic Syndrome Among Patients With Young-Onset Colorectal Cancer.
Dineen S; Lynch PM; Rodriguez-Bigas MA; Bannon S; Taggart M; Reeves C; Modaro C; Overman M; Chang GJ; Skibber JM; You YN
J Natl Compr Canc Netw; 2015 Jul; 13(7):865-72. PubMed ID: 26150580
[TBL] [Abstract][Full Text] [Related]
17. Isolated Loss of PMS2 Immunohistochemical Expression is Frequently Caused by Heterogenous MLH1 Promoter Hypermethylation in Lynch Syndrome Screening for Endometrial Cancer Patients.
Kato A; Sato N; Sugawara T; Takahashi K; Kito M; Makino K; Sato T; Shimizu D; Shirasawa H; Miura H; Sato W; Kumazawa Y; Sato A; Kumagai J; Terada Y
Am J Surg Pathol; 2016 Jun; 40(6):770-6. PubMed ID: 26848797
[TBL] [Abstract][Full Text] [Related]
18. Missed opportunities: Genetic counseling and testing among an ethnically diverse cohort of women with endometrial cancer.
Lee J; Gubernick LR; Brodsky AL; Fehniger JE; Levine DA; Gerber D; Asgari SA; Cantor A; Martineau JT; Ginsburg OM; Smith JA; Pothuri B
Gynecol Oncol; 2018 Oct; 151(1):153-158. PubMed ID: 30077346
[TBL] [Abstract][Full Text] [Related]
19. Lessons learnt from implementation of a Lynch syndrome screening program for patients with gynaecological malignancy.
Najdawi F; Crook A; Maidens J; McEvoy C; Fellowes A; Pickett J; Ho M; Nevell D; McIlroy K; Sheen A; Sioson L; Ahadi M; Turchini J; Clarkson A; Hogg R; Valmadre S; Gard G; Dooley SJ; Scott RJ; Fox SB; Field M; Gill AJ
Pathology; 2017 Aug; 49(5):457-464. PubMed ID: 28669579
[TBL] [Abstract][Full Text] [Related]
20. Universal Versus Targeted Screening for Lynch Syndrome: Comparing Ascertainment and Costs Based on Clinical Experience.
Erten MZ; Fernandez LP; Ng HK; McKinnon WC; Heald B; Koliba CJ; Greenblatt MS
Dig Dis Sci; 2016 Oct; 61(10):2887-2895. PubMed ID: 27384051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]